Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

Concurrent use of patiromer and high-dose MRAs reduces the risk of recurrent hyperkalemia (ClinicalTrials.gov: NCT03888066).